Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.3 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.044 | 0.3 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.3 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.049 | 0.3 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |